Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Bezafibrate

Related Products

Hot Products

Name

Bezafibrate

EINECS 255-567-9
CAS No. 41859-67-0 Density 1.26 g/cm3
PSA 75.63000 LogP 3.94540
Solubility DMF: soluble Melting Point 184 °C
Formula C19H20ClNO4 Boiling Point 572.1 °C at 760 mmHg
Molecular Weight 361.825 Flash Point 299.8 °C
Transport Information N/A Appearance Off-white solid
Safety 36 Risk Codes 22
Molecular Structure Molecular Structure of 41859-67-0 (Bezafibrate) Hazard Symbols HarmfulXn
Synonyms

Bezatol SR;LO 44;2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid;Bezalip;Prestwick_724;BF-759;Cedur;2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid;2-{4-[2-(4-chlorobenzamido)ethyl]phenoxy}-2-methylpropanoic acid;BM 15075;Propionic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-;

Article Data 8

Bezafibrate Synthetic route

104-76-7

2-Ethylhexyl alcohol

60-19-5

tyramine hydrochloride

122-01-0

4-chloro-benzoyl chloride

108-10-1

4-methyl-2-pentanone

isopropyl 3-bromo-2-methylpropionate

41859-67-0

bezafibrate

Conditions
ConditionsYield
With potassium hydroxide; sodium hydroxide; sulfuric acid; nitrogen; sodium hydrogencarbonate; potassium carbonate In water
67-66-3

chloroform

41859-57-8

4-chloro-N-(4-hydroxyphenethyl)benzamide

67-64-1

acetone

41859-67-0

bezafibrate

Conditions
ConditionsYield
With sodium hydroxide In water at 50 - 60℃; for 1.5h;
60-19-5

tyramine hydrochloride

41859-67-0

bezafibrate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide; sodium hydrogencarbonate / water / 3 h / 10 - 15 °C
2: sodium hydroxide / water / 1.5 h / 50 - 60 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium hydrogencarbonate / water / 0 - 20 °C / Inert atmosphere
2: sodium hydroxide / chloroform / 65 °C / Inert atmosphere
View Scheme
122-01-0

4-chloro-benzoyl chloride

41859-67-0

bezafibrate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide; sodium hydrogencarbonate / water / 3 h / 10 - 15 °C
2: sodium hydroxide / water / 1.5 h / 50 - 60 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium hydrogencarbonate / water / 3 h / 10 - 15 °C
2: sodium hydroxide / water / 1.5 h / 50 - 60 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium hydrogencarbonate / water / 0 - 20 °C / Inert atmosphere
2: sodium hydroxide / chloroform / 65 °C / Inert atmosphere
View Scheme
41859-57-8

4-chloro-N-(4-hydroxyphenethyl)benzamide

67-64-1

acetone

41859-67-0

bezafibrate

Conditions
ConditionsYield
With sodium hydroxide In chloroform at 65℃; Inert atmosphere;
847682-00-2

1,3-bis(2,2-dimethyl-1,3-dioxan-5-yloxy)propan-2-yl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate

41859-67-0

bezafibrate

1043468-91-2

1,3-bis(2,2-dimethyl-1,3-dioxan-5-yloxy)propan-2-yl 2-(4-(2-(4-chlorobenzamido)ethyl)phenoxy)-2-methylpropanoate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 1.5h; Inert atmosphere;98%
41859-67-0

bezafibrate

74-88-4

methyl iodide

methyl 2-(4-(2-(4-chlorobenzamido)ethyl)phenoxy)-2-methylpropanoate

Conditions
ConditionsYield
With potassium carbonate at 0 - 20℃; for 16h;96%
41859-67-0

bezafibrate

765-30-0

Cyclopropylamine

4-chloro-N-(4-((1-(cyclopropylamino)-2-methyl-1-oxopropan-2-yl)oxy)phenethyl)benzamide

Conditions
ConditionsYield
Stage #1: bezafibrate With 1,1'-carbonyldiimidazole In dichloromethane for 1h;
Stage #2: Cyclopropylamine In dichloromethane at 20℃; for 2h;
96%
10273-89-9

2-(2-methylphenyl)pyridine

41859-67-0

bezafibrate

C31H30N2O4

Conditions
ConditionsYield
With C17H24N5Ru(1+)*F6P(1-); potassium acetate; potassium carbonate In 1-methyl-pyrrolidin-2-one at 35℃; for 48h; Inert atmosphere;90%
With C17H24N5Ru(1+)*F6P(1-); potassium acetate; potassium carbonate In 1-methyl-pyrrolidin-2-one at 35℃; for 48h; Inert atmosphere; Glovebox;90%
84089-73-6, 91508-00-8

1-iodoethyl isopropyl carbonate

41859-67-0

bezafibrate

1415335-07-7

C25H30ClNO7

Conditions
ConditionsYield
Stage #1: bezafibrate With N,N,N',N'-tetramethylguanidine In N,N-dimethyl acetamide at -5℃; for 0.333333h; Inert atmosphere;
Stage #2: 1-iodoethyl isopropyl carbonate In N,N-dimethyl acetamide at -5℃; for 0.5h; Inert atmosphere;
88%

Bezafibrate Chemical Properties

IUPAC: 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid 
Molecular Formula: C19H20ClNO4
Molecular Weight: 361.82
EINECS: 255-567-9
Density: 1.26 g/cm3
Melting Point: 184 ºC
Boiling Point: 572.1 °C at 760 mmHg 
Flash Point: 299.8 °C
Solubility: soluble in DMF
Freely Rotating Bonds: 7
Polar Surface Area: 55.84 Å2
Index of Refraction: 1.583
Molar Refractivity: 95.99 cm3
Molar Volume: 287.1 cm3
Polarizability: 38.05 ×10-24 cm3
Surface Tension: 49.3 dyne/cm 
Enthalpy of Vaporization: 90.23 kJ/mol
Vapour Pressure: 6.29E-14 mmHg at 25°C
The Cas Register Number  of Bezafibrate is 41859-67-0.The chemical synonyms of Bezafibrate (CAS NO.41859-67-0) are 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]-2-methylpropanoic acid ; 2-[4-(2-[4-Chlorobenzamido]ethyl)-phenoxyl]-2-methylpropanoic acid ; 2-[4-(2-[4-Chlorobenzomido]ethyl)-phenoxy]-2-methylpropanoic acid ; 2-(4-(2-((4-Chlorobenzoyl)amino)ethyl)phenoxy)-2-methylpropionic acid ; Aurora ka-851 ; Bezafibrate ; Bezalip ; Cedur .Product categories of Bezafibrate (CAS NO.41859-67-0) are  Active pharmaceutical ingredients ; Intermediates and Fine Chemicals ; Pharmaceuticals ; Intracellular receptor .The molecular structure of Bezafibrate (CAS NO.41859-67-0) is.

Bezafibrate History

 Boehringer Mannheim first introduced Bezafibrate in 1977.

Bezafibrate Uses

 Bezafibrate (CAS NO.41859-67-0) is used as pharmaceutical ingredient ; pharmaceuticals and antilipemic.It is used for used for the treatment of hyperlipidaemia.

Bezafibrate Safety Profile

Hazard Codes: HarmfulXn
Risk Statements 22 
R22: Harmful if swallowed.
Safety Statements 36 
S36: Wear suitable protective clothing.
WGK Germany 1
RTECS UE8755000

Bezafibrate Specification

 Bezafibrate (CAS NO.41859-67-0) is one of the popular medicines available in today's medical field, which is very much effective against various diseases that affect human body. This medicine is one of the fast effective drugs included under the category, fibrate drug using in the medical field for treating the disease of hyperlipidaemia. Lowering the triglyceride and LDL cholesterol level in human blood and increasing the HDL level is the main functioning of this medicine. Boehringer Mannheim introduced the Bezafibrate - Canadian drug in the year 1977 as a valuable contribution to the medical field.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 41859-67-0